New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
08:56 EDTAMCC, FNSR, JMBA, FEYE, CNDO, GGS, S, EXC, RFIL, MU, GRPNOn The Fly: Pre-market Movers
HIGHER: FireEye (FEYE), up 23% after announcing a deal to acquire cybersecurity firm Mandiant and raising its bookings and revenue expectations... Global Geophysical (GGS), up 11% after deal for sale of AutoSeis HDR systems... Finisar (FNSR), up 3% after upgraded at Raymond James. LOWER: Jamba (JMBA), down 3.3% after downgraded at Wedbush... Groupon (GRPN), down 1.3% after filing to sell 13.8M shares of common stock for holder... Sprint (S), down 2% following downgrade at Stifel... Micron (MU), down 2% after downgraded at RBC Capital... RF Industries (RFIL), down 21.5% after reporting preliminary Q4 results... Coronado (CNDO), down 4% following downgrade at Oppenheimer... Applied Micro (AMCC), down 2.6% after downgraded at BMO Capital... Exelon (EXC), down 1.4% after being downgraded at Citigroup and BofA Merrill Lynch.
News For FEYE;GRPN;S;JMBA;MU;GGS;FNSR;RFIL;CNDO;AMCC;EXC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
February 23, 2015
10:32 EDTFEYEFireEye falls, levels to watch
Subscribe for More Information
10:15 EDTFEYECyberArk sinks after JPMorgan analyst cuts rating to sell
Subscribe for More Information
February 20, 2015
10:30 EDTGRPNOptions with decreasing implied volatility
Subscribe for More Information
09:08 EDTFEYEFireEye price target raised to $50 from $44 at UBS
UBS raised its price target on FireEye to $50 from $44 following meetings with management. The firm cited improved business trends, new partnerships and higher state and local government spending. UBS reiterated its Buy rating on FireEye shares.
February 19, 2015
11:31 EDTEXCConstellation selected by Federal Bureau of Prisons for $45M project
Subscribe for More Information
10:57 EDTSSprint commences $1B senior notes offering
Sprint announced that it has commenced an underwritten public offering of $1B aggregate principal amount of notes. Sprint intends to use the net proceeds for "general corporate purposes, which may include, among other things, working capital requirements, retirement or service requirements of outstanding debt and network expansion and modernization." The joint book-running managers for the offering are Citigroup, Goldman Sachs, .J.P. Morgan Securities, Merrill Lynch, Barclays, Credit Agricole, Credit Suisse, Deutsche Bank, Mitsubishi UFJ, Mizuho, RBC Capital, Scotia Capital and SMBC Nikko Securities.
10:52 EDTSSprint files automatic mixed securities shelf
Subscribe for More Information
10:44 EDTGRPNOptions with decreasing implied volatility
Options with decreasing implied volatility: VDSI KING ZU AVP GRPN SKX TRIP YPF UPL CYBR
February 18, 2015
10:32 EDTGRPNOptions with decreasing implied volatility
Subscribe for More Information
08:38 EDTCNDOCoronado in-licenses IV Tramadol from Revogenex Ireland
Coronado Biosciences has obtained an exclusive license to an intravenous formulation of tramadol for the U.S. market from Revogenex Ireland, a privately held company in Dublin, Ireland. Coronado has formed a wholly owned subsidiary, Avenue Therapeutics, Inc., to acquire, in-license, develop and commercialize products principally for use in the U.S. hospital market. Coronado will transfer the Revogenex license to Avenue Therapeutics, Inc. In addition to IV tramadol, Avenue Therapeutics plans to seek additional products. Tramadol is a centrally acting synthetic opioid analgesic for moderate to moderately severe pain. It is available as immediate release or extended-release tablets in the U.S. It has been reported that oral tramadol sales were approximately $1.2B in the U.S. in 2014.
08:19 EDTMUMicron profitability can improve meaningfully, says Bernstein
Subscribe for More Information
February 17, 2015
18:06 EDTSPaulson & Co gives quarterly update on stakes
Subscribe for More Information
17:13 EDTMUPoint72 gives quarterly update on stakes
Subscribe for More Information
13:18 EDTS, GRPNOmega Advisors gives quarterly update on stakes
Subscribe for More Information
10:51 EDTGRPNOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTMUOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:56 EDTMUMicron rises, levels to watch
Subscribe for More Information
07:50 EDTFEYEFireEye price target raised to $49 from $44 at BofA/Merrill
BofA/Merrill raised Buy rated FireEye's price target to $49 to reflect expected improvements in cash flow as investment in international infrastructure and M&A slows. The firm continues to view FireEye as a top pick given technological advantages, upside to billings and revenue growth, execution abilities, and strong sector trends.
07:41 EDTMUMicron price target raised to $45 from $42 at Jefferies
Subscribe for More Information
07:10 EDTMUMicron upgraded to Outperform from Neutral at Macquarie
Macquarie upgraded Micron to Outperform with a $40 price target based on expectations memory medium-term pricing trends will remain stable given structural supply constraints, which could result in $5B in free-cash-flow in CY16.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use